This is a condition where the body doesn't have enough of a type of white blood cell called CD4 T-cells. The 'idiopathic' part means doctors don't know the exact cause, but it's not due to an infection like HIV.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Idiopathic CD4-positive T-lymphocytopenia, usually shortened to ICL, is a rare immune disorder in which the blood has persistently too few CD4 T cells, named for the CD4 protein on their surface. These white blood cells coordinate much of the immune system's defense against viruses, fungi and certain bacteria. "Idiopathic" means the cause is unknown, and "lymphocytopenia" means a low count of lymphocytes, the family of white blood cells that CD4 cells belong to. ICL is defined partly by what it is not: the low count cannot be explained by HIV (human immunodeficiency virus) or by any other known cause of a weakened immune system. Because CD4 cells are central to fighting certain germs, people with ICL are more vulnerable to opportunistic infections, which take hold mainly when immunity is weakened. The most common are stubborn warts and other skin or genital disease caused by human papillomavirus (HPV), and cryptococcosis, a fungal infection that often reaches the brain and its lining. ICL also brings a higher rate of some cancers and of autoimmune conditions, in which the immune system attacks the body's own tissues. The picture varies widely. Some people are diagnosed only after a serious infection, while a minority have few or no problems for years.
Researchers do not know why ICL develops, and it may have more than one cause. Proposed explanations include the body making too few CD4 cells, destroying them too quickly, or holding them in tissues instead of the bloodstream. Many people with ICL also carry antibodies against their own immune cells, which may cause or worsen the low count. ICL is usually found in adults, most often in middle age, and affects both men and women. ICL is not HIV, and it is not caused by any known germ passed between people. When the Centers for Disease Control and Prevention (CDC) investigated the first cases in the early 1990s, including the people close to them, it found no evidence of a contagious cause. Some people who appear to have ICL turn out to have an inherited immune disorder caused by a change in a single gene. In a large study at the US National Institutes of Health (NIH), genetic testing found such a cause in about 7 percent of people. When that happens, the diagnosis changes to the specific genetic condition, which can shape treatment and matter for relatives.
ICL is usually suspected when an otherwise healthy person develops an infection typical of a weakened immune system, or when a blood test happens to show a low lymphocyte count. The key test is flow cytometry, a blood test that counts the different kinds of lymphocytes, including CD4 T cells. Results are reported as cells per cubic millimeter of blood. The diagnosis requires a CD4 count below 300, or CD4 cells making up less than 20 percent of all T cells, on at least two separate tests taken weeks apart. Repeating the test matters because a severe infection such as tuberculosis, steroid medicines and other temporary factors can lower the count for a while. Within ICL, lower numbers carry more risk: in the NIH study, people with counts below 100 had about five times the odds of an opportunistic infection compared with people whose counts were between 100 and 300. ICL is a diagnosis of exclusion, meaning other explanations have to be ruled out first. Testing typically includes repeated HIV tests, checks for related viruses such as human T-lymphotropic virus (HTLV), cytomegalovirus and Epstein-Barr virus, antibody (immunoglobulin) levels and autoimmune blood tests. Doctors also look for lymphoma, sarcoidosis, Sjogren's syndrome and medicines such as chemotherapy that suppress immunity. Genetic testing may be offered, particularly when relatives are affected or other features point to an inherited immune disorder.
There is no established treatment that corrects ICL itself, so care focuses on treating infections promptly, preventing the most dangerous ones and catching complications early. Infections that do occur usually respond to the standard treatments used for those infections in anyone, although some, such as cryptococcal infection, may call for a longer period of medicine afterward to keep them from coming back. Preventive medicine is chosen according to the CD4 count and each person's other risks, using thresholds borrowed from HIV care. An antibiotic such as trimethoprim-sulfamethoxazole is commonly used to prevent Pneumocystis pneumonia, a serious lung infection. Azithromycin, another antibiotic, can guard against mycobacterial infections, and fluconazole, an antifungal medicine, against some fungal ones. Because years of preventive medicine carry their own side effects, the decision is individualized, and some people are instead checked regularly with a blood test for early cryptococcal infection. Vaccines need extra planning. Live vaccines, which contain a weakened form of the germ, should be avoided. Other vaccines are generally given following guidance similar to that for people with weakened immunity, but they may work less well: in the NIH study, about a third of people did not make detectable antibodies after two doses of a COVID-19 mRNA vaccine, mostly those with lower counts. Autoimmune conditions are treated in the usual ways, but medicines that suppress the immune system can raise the risk of infection further and call for closer follow-up. For people with severe, recurring infections or HPV-related disease that keeps progressing, specialist centers have tried treatments aimed at rebuilding T cells. These include interleukin-2 and interleukin-7, immune-signaling proteins given by injection, and, rarely, a stem cell transplant from a matched donor. They have helped some people in small studies but remain experimental, and they are offered mainly through research studies or specialized centers.
ICL is usually a long-term condition, but it does not typically worsen steadily the way untreated HIV does. In the NIH study, CD4 counts stayed fairly stable or crept up slightly over the years. In a smaller earlier study, about one in five people saw their counts return to normal, after an average of about two and a half years. Why this happens for some people and not others is unknown. Outlook depends largely on infections and cancers rather than on the count alone. In the NIH study, which followed people for a median of three years, the death rate was similar to that of the general population, although the study was small and follow-up was short. Earlier reports described worse outcomes, which may partly reflect the severe cases that were most likely to be published. Cancer was more common than expected, particularly cancers linked to HPV (anal, genital, mouth and throat), non-Hodgkin lymphoma, thyroid cancer and Kaposi sarcoma. That is why regular cancer screening, including skin checks and genital and anal exams, is a central part of care. Living with ICL means ongoing follow-up with an immunology or infectious disease specialist, repeat blood counts, keeping up with any preventive medicines, and having new infections looked at early rather than waiting to see whether they clear.
Ask about an immune evaluation if you develop an infection usually seen only with a weakened immune system despite a negative HIV test, or warts or genital growths that keep spreading despite treatment. If you have ICL, bring new skin growths, sores that do not heal, lumps or swollen glands to your regular visits, and sooner if they are growing. Contact your care team promptly about a fever, a cough that does not go away, unexplained weight loss or night sweats, or gradual weakness, clumsiness, trouble speaking or vision changes that build over days to weeks. Infections in ICL can become serious, and treating them early matters. A headache with fever, especially with a stiff neck, sensitivity to light or vomiting, needs same-day medical assessment, because cryptococcal meningitis, a fungal infection of the brain's lining, is one of the most common serious complications. Call 911 for a seizure or sudden confusion.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Idiopathic CD4-Positive T-Lymphocytopenia is like, what's helped you, or ask the community a question.